Lilly Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 81
  • Portfolio
  • 5
  • Exits
  • 43
Exits

Lilly Ventures General Information

Description

Founded in 2002, Lilly Ventures is a corporate venture capital arm of Lilly Ventures. The firm is based in Indianapolis, Indiana. The firm prefers to invest in life science sector.

Contact Information

Year Founded
2002
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 115 West Washington Street
  • Suite 1680 - South
  • Indianapolis, IN 46204
  • United States
+1 (317) 000-0000

Lilly Ventures Investments (81)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Sutro Biopharma 26-Jul-2018 Later Stage VC 000.00 Drug Delivery Generating Revenue/Not Profitable 00000 000000000 00.0
000000 00000000000 05-Jun-2018 00000 00000 0000 Drug Discovery Generating Revenue 000000 0000 00.0
000000 00000000000 30-Oct-2017 00000 00000 0000 Biotechnology Generating Revenue/Not Profitable 000000 0000 00.0
00000 000 22-May-2017 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000 000000000 00.0
000000 10-Apr-2017 00000 00000 00.000 Drug Discovery Out of Business 000000 0000 00.0
000000000 00000000 13-Jan-2017 00000 00000 000.00 Drug Discovery Generating Revenue 000000 0000 00.0
0000000 0000000000 06-Jan-2017 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 00000 000000000 00.0
000000 06-Jan-2017 00000 00000 000.00 Pharmaceuticals Clinical Trials - Phase 2 000000 0000 00.0
Protagonist Therapeutics 11-Aug-2016 IPO 0000 Biotechnology Generating Revenue/Not Profitable 00000 000000000 00.0
Symic Bio 01-Dec-2015 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2 00000 000000000 00.0
You’re viewing 10 of 81 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lilly Ventures Exits (43)

Company Name Exit Date Exit Type Exit Size
Kymera Therapeutics 02-Jul-2021 Public Investment 2nd Offering 00000
00000000000 000000 17-Jun-2021 000000 0000000000 00000
0000000 24-Feb-2021 0000000 000000
00000 000000000000 11-Dec-2020 000000 0000000000 00000
000000000 00000000 01-Oct-2020 000000000000000000
000000 00000000000 21-Aug-2020 000 00000
00000 000000000000 19-Jun-2020 000 00000
00000000 01-Nov-2019 000000000000000000
Innocrin Pharmaceuticals 01-Oct-2019 Out of Business
Cavion 12-Aug-2019 Merger/Acquisition 00000
You’re viewing 10 of 43 exits. Get the full list »

Lilly Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Lilly Ventures Team (13)

Name Title Deals Funds Boards Office
S. Edward Torres Founder and Managing Director 00 0 0 Indianapolis, IN
Steven Hall Ph.D General Partner 00 0 0 Indianapolis, IN
Lisa Belas Office Manager Indianapolis, IN
You’re viewing 3 of 13 team members. Get the full list »

Lilly Ventures Co-Investors (34)

Name With Exits Lead Partner Series Industry
Atlas Venture 3 0 0 Series chart Industry bar
Amgen Ventures 0 0 Series chart Industry bar
Novartis Venture Fund 0 0 0 Series chart Industry bar
Citadel (Hedge Fund) 0 0 Series chart Industry bar
Merck 0 0 Series chart Industry bar
You’re viewing 5 of 34 co-investors. Get the full list »